ArticleBMC cancer2026

Adebrelimab plus chemotherapy as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESCC): a single-center, phase II, single-arm, open-label clinical trial (ADENEO) protocol.

Peng Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.